Product Information

LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB is a generic product labeled by Solco Healthcare US LLC, priced at $0.0573 per EA under NDC 43547042311. Its NADAC has been published 423 times since Jul 18, 2018.

FDA first approved this application on Nov 6, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB

losartan potassium and hydrochlorothiazide
$0.0573per EA

Strength

12.5; 50 mg/1; mg/1

NDC

43547042311

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA204901

FDA Approved

11/6/2017

TE Code

AB

On Market Since

2/15/2018

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB has been published 423 times since Jul 18, 2018, and over the history we have for it it has declined 21.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0573 per EA
All-time high$0.1854 (Apr 15, 2020)
All-time low$0.0573 (Aug 19, 2026)
52-week high$0.0797
52-week low$0.0573
Median price$0.0970
Average price$0.1101
Largest weekly change+46.8% (Dec 18, 2019)
Weeks tracked423
Tracking sinceJul 18, 2018

Price History

1W

-4.7%

1M

-4.7%

3M

-7.3%

6M

-18.7%

1Y

-28.1%

3Y

-44.0%

5Y

-62.3%

All

-21.8%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB, manufactured by Solco Healthcare US LLC, is $0.0573 per EA (NDC 43547042311), effective Aug 19, 2026.

How has the price of LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB has declined 21.8%. It has been tracked across 423 weekly CMS publications since Jul 18, 2018.

What are the highest and lowest recorded NADAC prices for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB?

Since Jul 18, 2018, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB has ranged from a low of $0.0573 (Aug 19, 2026) to a high of $0.1854 (Apr 15, 2020), with a median of $0.0970 per EA.

Are there cheaper alternatives to LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB?

LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB (NDC 43547042311) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.